Co-tenidone
Co-tenidone (BAN) is a non-proprietary name used to denote a combination of atenolol and chlortalidone. Co-tenidone is used in the treatment of hypertension. The use of β-blockers in hypertension was downgraded in June 2006 in the United Kingdom to fourth-line because they perform less well than other drugs, and because atenolol, the most frequently used β-blocker, at usual doses carries an unacceptable risk of provoking type 2 diabetes.[1]
| Combination of | |
|---|---|
| Atenolol | Beta blocker |
| Chlortalidone | Thiazide diuretic |
| Clinical data | |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
| Identifiers | |
| ChemSpider | |
| (verify) | |
Formulation
Two strengths of co-tenidone are currently available in the UK:
- 50 mg atenolol and 12.5 mg chlortalidone, BAN of Co-tenidone 50/12.5
- 100 mg atenolol and 25 mg chlortalidone, BAN of Co-tenidone 100/25
gollark: Hmm, thus Macron bad?
gollark: Did you know? Golang has `nil`, thus Golang bad.
gollark: never, probably?
gollark: ~search LyricLy
gollark: void.tennis.
References
- British National Formulary 54, September 2007
Footnotes
- Sheetal Ladva (2006-06-28). "NICE and BHS launch updated hypertension guideline". National Institute for Health and Clinical Excellence.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.